Slim Linear Ultrasound Endoscope

Houston Methodist Hospital and Siemens Healthineers have entered into a multi-year agreement to bring cutting-edge technology to Houston Methodist that is not currently available in the Texas Medical Center. This agreement will provide innovative, world-class medical technology to Houston Methodist Hospital and all of its community hospital facilities.

Synergy 2017: A Multidisciplinary Approach to Interventional Oncology

It's critical for today's healthcare professionals to understand the balance between the risks and benefits of any X-ray imaging procedure.

ScImage Inc. was recently awarded a new DIN-PACS IV (Digital Imaging Network/Picture Archiving and Communications System) contract by the U.S. government. The contract is potentially valued up to $400 million, and the terms include one five-year base period and one five-year option period.

Carestream Health recently introduced new MR (magnetic resonance) Brain Perfusion and MR Brain Diffusion modules that enable radiologists to read these imaging studies from a Carestream Vue PACS (picture archiving and communication system) diagnostic viewer. The company has received U.S. Food and Drug Administration (FDA) 510(k) clearance for use in the United States, and these new tools also have been approved for use in Europe and other countries across the globe.

August 16, 2017 — Mach7 Technologies Inc. welcomed Michael Jackman as their new chief executive officer (CEO) to help accelerate Mach7’s vision for the future of enterprise imaging. Mr. Jackman is an accomplished executive with nearly 30 years’ experience of energizing teams, building brands and creating value in highly successful global healthcare IT businesses, according to Mach7.

In the featured translational article in the August issue of The Journal of Nuclear Medicine, researchers at the University of Michigan demonstrate the potential of a new positron emission tomography (PET) tracer, Carbon-11 labeled sarcosine (11C-sarcosine), for imaging prostate cancer. The article also sets the stage for its possible use in monitoring other cancers.

X-ray of a knee replacement. CMS may change reimbursements for joint and knee replacements. Patient Marilyn Fornell.

August 16, 2017 — The Centers for Medicare and Medicaid Services (CMS) announced a proposed rule to reduce the number of mandatory geographic areas participating in the Center for Medicare and Medicaid Innovation’s (Innovation Center) Comprehensive Care for Joint Replacement (CJR) model from 67 to 34. In addition, CMS proposes to allow CJR participants in the 33 remaining areas to participate on a voluntary basis. In this rule, CMS also proposes to make participation in the CJR model voluntary for all low-volume and rural hospitals in all of the CJR geographic areas.

The International Society for Magnetic Resonance in Medicine (ISMRM) has provided new guidance in the use of contrast agents during MRI scans. Emerging research suggests gadolinium-based contrast agents, injected in a patient's veins to brighten tissues in MRI images, accumulate in the brain. More than 300 million doses of such drugs have been administered since their introduction in 1987.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now